Boston-based research device developer 908 Devices completed its $125 million initial public offering, and its shares are now available to trade on the Nasdaq under the ticker "MASS." Shares are available for limit orders via Robinhood.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Social investors
| Latest market close | $42.13 |
|---|---|
| 52-week range | $20.00 - $79.60 |
| 50-day moving average | $36.97 |
| 200-day moving average | $48.67 |
| Wall St. target price | $60.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | N/A |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $42.13 from 2021-05-28
| 1 week (2021-07-25) | N/A |
|---|---|
| 1 month (2021-07-02) | 21.66% |
| 3 months (2021-05-05) | -19.23% |
| 6 months (2021-02-01) | N/A |
| 1 year (2020-08-01) | N/A |
|---|---|
| 2 years (2019-08-01) | N/A |
| 3 years (2018-08-01) | N/A |
| 5 years (2016-08-01) | N/A |
| Revenue TTM | $28.4 million |
|---|---|
| Gross profit TTM | $14.9 million |
| Return on assets TTM | -3.36% |
| Return on equity TTM | -22.48% |
| Profit margin | -56.08% |
| Book value | $4.88 |
| Market capitalisation | $843 million |
TTM: trailing 12 months
There are currently 2.0 million 908 Devices shares held short by investors – that's known as 908 Devices's "short interest". This figure is 9.5% up from 1.8 million last month.
There are a few different ways that this level of interest in shorting 908 Devices shares can be evaluated.
908 Devices's "short interest ratio" (SIR) is the quantity of 908 Devices shares currently shorted divided by the average quantity of 908 Devices shares traded daily (recently around 473174.17840376). 908 Devices's SIR currently stands at 4.26. In other words for every 100,000 908 Devices shares traded daily on the market, roughly 4260 shares are currently held short.
To gain some more context, you can compare 908 Devices's short interest ratio against those of similar companies.
However 908 Devices's short interest can also be evaluated against the total number of 908 Devices shares, or, against the total number of tradable 908 Devices shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case 908 Devices's short interest could be expressed as 0.07% of the outstanding shares (for every 100,000 908 Devices shares in existence, roughly 70 shares are currently held short) or 0.1454% of the tradable shares (for every 100,000 tradable 908 Devices shares, roughly 145 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against 908 Devices.
Find out more about how you can short 908 Devices stock.
We're not expecting 908 Devices to pay a dividend over the next 12 months.
You may also wish to consider:
908 Devices Inc. develops and sells measurement devices for chemical and biochemical analysis in North America, Europe, the Middle East, Africa, and the Asia Pacific. It offers handheld and desktop mass spectrometry (Mass Spec) devices for the point-of-need applications in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. 908 Devices Inc. was incorporated in 2012 and is headquartered in Boston, Massachusetts. .
Everything we know about the Chobani IPO, plus information on how to buy in.
Everything we know about the Stronghold Digital Mining IPO, plus information on how to buy in.
Everything we know about the ROX Financial LP IPO, plus information on how to buy in.
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
Everything we know about the RenovoRx IPO, plus information on how to buy in.
Everything we know about the Draganfly IPO, plus information on how to buy in.
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
Everything we know about the Marpai IPO, plus information on how to buy in.
